Concepedia

Herbert Gritsch

HG

Statistics

Publications

14

Citations

589

H-Index

13

Active since

1997

Affiliations

Baxter (Austria)(Current)

Takeda (Austria)

Baxter (United States)

Takeda (United States)

Azienda Ospedaliera Universitaria Integrata Verona

Herbert Gritsch is an author at Baxter (Austria) specializing in medicine, hemostasis, and hematology.

Publications per year

1997–2023

14

Publications

14

BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisation.

Peter L. Turecek, M.J. Bossard, Michael Graninger et al. · PubMed · 2012 · 96 citations

Medicine, Biotechnology, Pharmacology +13

A world‐wide survey and field study in clinical haemostasis laboratories to evaluate <scp>FVIII</scp>:C activity assay variability of <scp>ADYNOVATE</scp> and <scp>OBIZUR</scp> in comparison with <scp>ADVATE</scp>

Peter L. Turecek, S. Romeder‐Finger, Christopher Apostol et al. · Haemophilia · 2016 · 70 citations · Full text

Medicine, Hematology, Good Laboratory Practice +13

Factor Xa and Prothrombin: Mechanism of Action of FEIBA

Peter L. Turecek, Katalin Váradi, Herbert Gritsch et al. · Vox Sanguinis · 1999 · 64 citations

Medicine, Hematology, Hematology Physiology +15

Development of a plasma- and albumin -free recombinant von Willebrand factor

Peter L. Turecek, Artur Mitterer, H. Peter Matthiessen et al. · Hämostaseologie · 2009 · 59 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

In Vivo Characterization of Recombinant von Willebrand Factor in Dogs With von Willebrand Disease

Peter L. Turecek, Herbert Gritsch, Ludwig Pichler et al. · Blood · 1997 · 53 citations · Full text

Medicine, Pathobiology, Hemostasis +10

1–5 of 14